Pre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study.

2.50
Hdl Handle:
http://hdl.handle.net/10541/621022
Title:
Pre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study.
Authors:
Crona, J; Lamarca, Angela; Ronot, M; Opalinska, M; Lopez, C; Pezzutti, D; Trueba, H; Carvhalo, L; de Mestier, L; Najran, Pavan; Pavel, M; Dromain, C
Affiliation:
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Citation:
Pre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study. 2018, 106: 171-171 Neuroendocrinology
Journal:
Neuroendocrinology
Issue Date:
2018
URI:
http://hdl.handle.net/10541/621022
Type:
Meetings and Proceedings
Language:
en
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorCrona, Jen
dc.contributor.authorLamarca, Angelaen
dc.contributor.authorRonot, Men
dc.contributor.authorOpalinska, Men
dc.contributor.authorLopez, Cen
dc.contributor.authorPezzutti, Den
dc.contributor.authorTrueba, Hen
dc.contributor.authorCarvhalo, Len
dc.contributor.authorde Mestier, Len
dc.contributor.authorNajran, Pavanen
dc.contributor.authorPavel, Men
dc.contributor.authorDromain, Cen
dc.date.accessioned2018-05-15T20:22:28Z-
dc.date.available2018-05-15T20:22:28Z-
dc.date.issued2018-
dc.identifier.citationPre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study. 2018, 106: 171-171 Neuroendocrinologyen
dc.identifier.urihttp://hdl.handle.net/10541/621022-
dc.language.isoenen
dc.titlePre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Medical Sciences, Uppsala University, Uppsala, Swedenen
dc.identifier.journalNeuroendocrinologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.